“Counterfeiting is a widespread problem that poses severe and complex implications for health professionals and patients,” said Dr. Myra T. Olm, Director, Brand Protection Research and Product Development, Security Solutions, Kodak’s Business Solutions and Services Group. “Kodak’s strategic portfolio of services, based on its expertise in materials science and imaging science, allows us to consult with our customers and deliver specialized countermeasures that strengthen multiple aspects of their packaging.”

The IQPC seminar will also include discussions on other programs and policies being implemented to equip brand owners and protect consumers against counterfeit and substandard pharmaceuticals and medicines. The World Health Organization estimates global sales of counterfeit and substandard medicines generates more than $32 billion each year. Kodak’s experts will be available to share best practices, tools and technologies available for building and implementing a comprehensive brand protection strategy.

“Pharmaceutical and medical device manufacturers require an end-to-end approach to address the multiple layers of protection required to defend against counterfeiting,” said Roberto D. Colangelo, General Manager, Worldwide Services, Vice President, Kodak’s Business Solutions and Services Group. “At Kodak, we begin with a complete assessment that allows us to design, protect, monitor and enforce a comprehensive and highly-effective brand protection strategy.”

KODAK Security Solutions bring together the resources of Kodak’s vast intellectual property portfolio, along with expertise in material science, digital imaging, document imaging, and graphic communications to create a broad portfolio of products and technologies that protect against counterfeiting. Information on Security Solutions is available at www.graphics.kodak.com/US/en/Application_Solutions/Enterprise/brand_protection